{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/whooping-cough/management/management-of-whooping-cough/","result":{"pageContext":{"chapter":{"id":"be786901-8aa4-5cf6-977f-07c667507f85","slug":"management-of-whooping-cough","fullItemName":"Scenario: Management of whooping cough","depth":2,"htmlHeader":"<!-- begin field 6ac13dec-42dc-41a1-833f-4c724b8ec13b --><h2>Scenario: Management of whooping cough</h2><!-- end field 6ac13dec-42dc-41a1-833f-4c724b8ec13b -->","summary":"Covers the management of people with suspected or confirmed whooping cough and their close contacts.","htmlStringContent":"<!-- begin item b70a6564-aab9-4d7a-8c1d-d36ae1ab74e8 --><!-- begin field d9b57f2c-633f-4ad8-b40a-acbc015a1a5e --><p>From birth onwards.</p><!-- end field d9b57f2c-633f-4ad8-b40a-acbc015a1a5e --><!-- end item b70a6564-aab9-4d7a-8c1d-d36ae1ab74e8 -->","topic":{"id":"35659c4f-d80b-5e8b-8b62-22146482d6da","topicId":"aa36f776-3bec-44aa-ba6f-c147b57f7328","topicName":"Whooping cough","slug":"whooping-cough","lastRevised":"Last revised in January 2021","chapters":[{"id":"57f71ac2-7f00-5c54-b9dc-d2d7d9425e4f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"43ee7c18-a7d1-5aaf-b7b1-e9f8aec21522","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"c127e190-a190-5b44-9ef6-9f30b6527b35","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"86a8dc5e-4401-57e4-a893-30e9405e7e8d","slug":"changes","fullItemName":"Changes"},{"id":"f0e375ca-3710-5454-996c-600b6987bc09","slug":"update","fullItemName":"Update"}]},{"id":"9165fc1a-9d30-5e58-9bb2-a1b68eab43c6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"39a4fa70-e2db-566b-9c9e-0be39b8be0ac","slug":"goals","fullItemName":"Goals"},{"id":"7fd8bab1-ed01-583f-925f-50b956b1065b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4c330a84-fe34-5261-acf3-bcd6c9b9d2ef","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"dab08320-4d0b-59e9-b25a-28f9cc15908b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a088fcbf-b960-56c1-a102-2cb980dc3cb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"05a22688-4243-5ec9-814d-874c82306da6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"32d067f6-839d-500a-9f89-494e3487c3fd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"76a32750-044c-5bf9-b055-60be74d61d05","slug":"definition","fullItemName":"Definition"},{"id":"ba541f69-d5c7-5bfb-bcef-ec03ceaceee7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5d07a89e-bdd9-5e79-81eb-87c32d271af2","slug":"prognosis","fullItemName":"Prognosis"},{"id":"054c3198-af7f-5c25-8611-2cc61ad8a848","slug":"complications","fullItemName":"Complications"}]},{"id":"41fa1350-a42e-56da-b04d-aba216545b35","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6eb9d7f5-32ca-5aaa-b5f3-1ac34aeff0d6","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"02ae0369-3f8d-5a31-b677-d0a1d5d0e6f9","slug":"making-a-clinical-diagnosis","fullItemName":"Making a clinical diagnosis"},{"id":"0a55b0ed-e1e6-5bf2-a57c-ec4bda345338","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"95029ae8-217f-53b1-b552-1b19a63a1460","slug":"notification-confirmation","fullItemName":"Notification and confirmation"}]},{"id":"e9f5a777-75d4-5e44-9222-d0679a35b79f","fullItemName":"Management","slug":"management","subChapters":[{"id":"be786901-8aa4-5cf6-977f-07c667507f85","slug":"management-of-whooping-cough","fullItemName":"Scenario: Management of whooping cough"}]},{"id":"73184dce-2f33-555a-99f5-1f7676165d85","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"c6240279-15ed-57da-bbbc-a009ed1fe10d","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"f55a7bd1-232f-5264-b591-1615754d7cd4","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"69df3991-1f78-5988-a277-eba775516ffc","slug":"azithromycin","fullItemName":"Azithromycin"},{"id":"83991d80-1c24-5213-80d8-d98f94f7165f","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"},{"id":"9e55dced-d32c-53b0-9767-ec433fb86549","slug":"paracetamol","fullItemName":"Paracetamol"},{"id":"6a290b31-ff8d-56f2-aa28-4f7fc47c5ff6","slug":"ibuprofen","fullItemName":"Ibuprofen"}]},{"id":"0cb3e998-9c97-56e6-86e8-373f09a16cee","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"06233f93-f6af-5a86-a0d3-f66b18e22f6f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"933608bb-6634-5ada-9704-c47966180200","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b65931da-6bf7-5353-a3e6-b7b3f0da241d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9e63923e-f250-5bb8-b436-8c4426b094d4","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8a644bf0-15a8-56ea-a310-b3625c09b8ce","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4da49df8-81c2-588b-aaf2-014b7ddf9181","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"20d6c374-e4e4-55e9-8247-f63253537476","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e9f5a777-75d4-5e44-9222-d0679a35b79f","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"fb60b7e2-2457-5dce-9f9a-5b10752ad5c4","slug":"management-of-whooping-cough","fullItemName":"Management of whooping cough","depth":3,"htmlHeader":"<!-- begin field ccf2cf45-2029-4e4f-9000-ccc589661043 --><h3>How should I manage whooping cough?</h3><!-- end field ccf2cf45-2029-4e4f-9000-ccc589661043 -->","summary":null,"htmlStringContent":"<!-- begin item f679d9fe-65fa-483e-9627-2780d75fb39a --><!-- begin field ec01b271-41fa-4636-9e26-70f77b9f23cc --><ul><li><strong>Arrange admission if the person:</strong><ul><li>Is 6 months of age or younger and acutely unwell.</li><li>Has significant breathing difficulties (for example apnoea episodes, severe paroxysms, or cyanosis).</li><li>Has a significant complication (for example seizures or pneumonia).<ul><li>Note: inform the hospital of the need for appropriate isolation before the person is admitted.</li></ul></li></ul></li><li><strong>If admission is not needed, prescribe an antibiotic if the onset of cough is within the previous 21 days. </strong>A macrolide antibiotic is recommended first-line:<ul><li>Prescribe clarithromycin for infants less than 1 month of age.</li><li>Prescribe azithromycin or clarithromycin for children aged 1 month or older, and non-pregnant adults.</li><li>Prescribe erythromycin for pregnant women.<ul><li>From 36 weeks' gestation, this is recommended to reduce the risk of transmission to the newborn baby.</li><li>Prior to this, it is likely to be of clinical benefit for the woman only if administered within the first 21 days of the illness, or may be advised if she is likely to come into close contact with a person from a <a class=\"topic-reference internal-reference\" href=\"/topics/whooping-cough/management/management-of-whooping-cough/#management-of-contacts\">vulnerable group</a>.</li></ul></li><li>Prescribe co-trimoxazole if macrolides are contraindicated or not tolerated (off-label indication). However, co-trimoxazole is contraindicated during pregnancy, and is not licensed for use in infants younger than six weeks of age.</li><li>For full information on dosing regimens, contraindications, and adverse effects of antibiotics, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/whooping-cough/prescribing-information/\">Prescribing information</a>.</li></ul></li><li><strong>Offer information and advice to the person and their family/carers:</strong><ul><li>Advise rest, adequate fluid intake, and the use of paracetamol or ibuprofen for symptomatic relief. For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a>.</li><li>Inform the person that, even with antibiotic treatment, whooping cough is likely to cause a protracted non-infectious cough that may take several weeks to completely resolve. Symptoms are likely to be less severe and resolve more quickly if the person has been immunized or has had pertussis before.</li><li>Advise the person to seek medical advice if they develop clinical features of any <a class=\"topic-reference internal-reference\" href=\"/topics/whooping-cough/background-information/complications/\">complications</a>.</li><li>Advise that children and healthcare workers who have suspected or confirmed whooping cough should stay off nursery, school, or work until 48 hours of appropriate antibiotic treatment has been completed, or 21 days after onset of symptoms if not treated.<ul><li>People who work in other settings should avoid contact with infants under one year of age who are unvaccinated or partially vaccinated until 48 hours of appropriate antibiotic treatment has been completed, or 21 days after onset of symptoms if not treated.</li></ul></li></ul></li><li><strong>When the person has recovered from the acute illness, arrange for them to have any outstanding vaccinations. </strong>For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-childhood/\">Immunizations - childhood</a>.</li></ul><!-- end field ec01b271-41fa-4636-9e26-70f77b9f23cc --><!-- end item f679d9fe-65fa-483e-9627-2780d75fb39a -->","subChapters":[{"id":"cf51d0d3-cd06-5f8a-b953-e466b2e55a35","slug":"basis-for-recommendation-add","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field c5a7482c-a78e-4f23-b0cf-794109a5b08b --><h4>Basis for recommendation</h4><!-- end field c5a7482c-a78e-4f23-b0cf-794109a5b08b -->","summary":null,"htmlStringContent":"<!-- begin item add034b4-eca8-4cdc-af7f-e7d6ec3736ac --><!-- begin field ba85173b-9dc7-4a15-a943-28737259239f --><h5>When to admit</h5><ul><li>These recommendations are based on expert opinion in a narrative review and reflect the potentially serious complications of whooping cough in young children.<ul><li>The mortality rate for pertussis in children of 6 months of age or less is estimated to be 3.5%, compared with 0.03% in the general population [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Frydenberg and Starr, 2004</a>].</li></ul></li></ul><h5>Informing the hospital of the requirement for isolation prior to admission</h5><ul><li>This recommendation is based on expert opinion in the Public Health England (PHE) <em>Guidelines for the public health management of pertussis in healthcare settings </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">PHE, 2016e</a>], that people with whooping cough in hospital should be treated in respiratory isolation.</li></ul><h5>Antibiotic treatment in primary care</h5><ul><li>These recommendations are based on the PHE <em>Guidelines for the public health management of pertussis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">PHE, 2016b</a>] which states that:<ul><li>Treatment should only be commenced if the person presents within 3 weeks of symptom onset because the effect of antibiotics on reducing symptoms is limited, especially when given late during whooping cough.</li><li>Clarithromycin is the preferred antibiotic for use in neonates, as there are limited data on the use of azithromycin in this age group.</li><li>Azithromycin and clarithromycin are the preferred antibiotics in all people aged over 1 month (except pregnant women). </li><li>Erythromycin is the preferred antibiotic for treating women in the last month of pregnancy to prevent transmission of whooping cough to the neonate. Although it is generally considered safe to use erythromycin earlier in pregnancy, any such decision should be based on the likely benefit for the woman (which is primarily determined by whether illness onset was within the preceding 21 days) and/or the presence of any vulnerable close contacts.</li><li>Co-trimoxazole is an alternative if macrolides are contraindicated but is not licensed for the treatment or prophylaxis of whooping cough, or for use in infants younger than six weeks of age.</li></ul></li><li>In addition, an article reviewing antibiotic treatments for pertussis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Kerr and Preston, 2001</a>] states that macrolides are recommended as first-line treatment because they:<ul><li>Exhibit favourable pharmacokinetic properties.</li><li>Have good in vitro activity against <em>Bordetella pertussis</em>.</li><li>Have a well-established safety profile.</li><li>Are rarely associated with bacterial resistance.</li></ul></li><li>A Cochrane systematic review that investigated the effectiveness of antibiotics in the treatment of whooping cough [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Altunaiji et al, 2007</a>] concluded that:<ul><li>Antibiotics are effective at eradicating <em>Bordetella pertussis </em>(and therefore preventing transmission) but probably do not significantly alter the clinical course of the disease.</li><li>For the purpose of eradication, azithromycin, clarithromycin, and co-trimoxazole are equally effective.</li></ul></li></ul><h5>Advice on symptomatic relief</h5><ul><li>The recommendation to advise that adequate fluid intake should be maintained when symptoms of upper respiratory tract infection are present is pragmatic, based on what CKS considers to be good medical practice. Whooping cough may also cause severe post-tussive vomiting which can lead to significant dehydration [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Waters and Halperin, 2010</a>].</li><li>The recommendation to use paracetamol and ibuprofen for the symptomatic relief of infection is based on evidence that they reduce fever and pain (including headache and myalgia).<ul><li>The antipyretic and analgesic efficacy of paracetamol and ibuprofen have been confirmed by randomized controlled trials on several conditions, including other upper respiratory tract infections (influenza and the common cold) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Eccles, 2006</a>].</li><li>The National Institute for Health and Care Excellence (NICE) recommends that antipyretic drugs 'should be considered in children with fever who appear distressed or unwell'. However, the routine use of antipyretic drugs to reduce temperature in children with no other symptoms or discomfort is not recommended [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">NICE, 2013</a>].</li></ul></li></ul><h5>Advice on exclusion from nursery, school, or work</h5><ul><li>The PHE guidance states that children and healthcare workers with suspected whooping cough should stay off nursery, school, or work until 48 hours of appropriate antibiotic treatment has been completed, or 21 days after onset of symptoms if not treated [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">PHE, 2016b</a>].<ul><li>This is primarily to prevent the spread of infection, as pertussis is most infectious at this stage.</li></ul></li><li>Young infants (6 months of age and younger) have a mortality rate which is 100-fold greater than for adults [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Frydenberg and Starr, 2004</a>], and special care should be taken to ensure they are not exposed to pertussis before their primary vaccinations at 4 months of age.</li></ul><!-- end field ba85173b-9dc7-4a15-a943-28737259239f --><!-- end item add034b4-eca8-4cdc-af7f-e7d6ec3736ac -->","subChapters":[]}]},{"id":"ce691dd3-8acc-52fe-8be8-60be84148d29","slug":"management-of-contacts","fullItemName":"Management of contacts","depth":3,"htmlHeader":"<!-- begin field 1f7c354a-224a-4d58-8619-933afb3940f5 --><h3>How should I manage contacts?</h3><!-- end field 1f7c354a-224a-4d58-8619-933afb3940f5 -->","summary":null,"htmlStringContent":"<!-- begin item a920928f-5277-4f9e-ac5f-1836b36163d7 --><!-- begin field e1cd7ba9-73b2-47a6-b045-0e5d1dfbe14e --><ul><li><strong>Offer antibiotic prophylaxis to close contacts of the ‘index case’ with suspected or confirmed pertussis (such as those living in the same household, or with overnight stays in the same room in an institutional setting), </strong>when the symptoms in the 'index case’ occurred within the previous 21 days, <em>and </em>the close contact is in one of the following priority groups:<ul><li><strong>Group 1 </strong>(infants at increased risk of severe complications from pertussis) includes:<ul><li>Unimmunised infants (born before 32 weeks gestation) less than 2 months of age regardless of maternal vaccine status.</li><li>Unimmunised infants (born after 32 weeks gestation) less than 2 months of age whose mothers did not receive maternal pertussis vaccine after 16 weeks and at least 2 weeks before delivery.</li><li>Infants aged 2 months or over who are unimmunised or partially immunised (less than three doses of DTaP/IPV/Hib up to 1 year of age) regardless of maternal vaccine status.</li></ul></li><li><strong>Group 2 </strong>(people at increased risk of transmitting infection to infants in Group 1 <em>and </em>who have not received a pertussis-containing vaccine more than 1 week and less than 5 years ago) includes:<ul><li>Pregnant women at 32 weeks’ gestation or more.</li><li>Healthcare workers who work with infants and pregnant women.</li><li>People whose work involves regular close or prolonged contact with infants too young to be fully vaccinated.</li><li>People who share a household with an infant too young to be fully vaccinated.</li></ul></li></ul></li><li><strong>Prescribe a macrolide antibiotic first-line.</strong><ul><li>Clarithromycin is preferred in infants less than 1 month of age.</li><li>Azithromycin or clarithromycin are preferred in children aged 1 month or older, and in non-pregnant adults.</li><li>Erythromycin is the macrolide of choice for pregnant women.</li><li>Co-trimoxazole is recommended if macrolides are contraindicated or not tolerated (off-label indication).</li><li>For full information on dosing regimens, contraindications, and adverse effects of antibiotics, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/whooping-cough/prescribing-information/\">Prescribing information</a>.</li></ul></li><li><strong>Advise that exclusion from nursery, school, or work for asymptomatic contacts is not required.</strong></li><li><strong>Offer immunization to all people who have been offered antibiotic prophylaxis.</strong><ul><li>Non-immunized and partly-immunized contacts up to 10 years of age should complete the schedule of the Childhood Immunization Programme with the appropriate vaccination. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-childhood/\">Immunizations - childhood</a>.</li><li>A booster dose of pertussis-containing vaccine is recommended for people aged 10 years or older who have not received a dose of tetanus-diphtheria-inactivated polio vaccine (Td-IPV) in the preceding month, and have not received a pertussis booster in the past 5 years.</li><li>Pregnant women who receive a dose of pertussis-containing vaccine before the 16th gestational week should also be given a further dose after 16 weeks of pregnancy to protect the neonate.</li></ul></li></ul><!-- end field e1cd7ba9-73b2-47a6-b045-0e5d1dfbe14e --><!-- end item a920928f-5277-4f9e-ac5f-1836b36163d7 -->","subChapters":[{"id":"470eb6b7-7b7b-5484-b426-ef3ccc277ea0","slug":"basis-for-recommendation-509","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field fd8a090a-7a3a-4957-bbf2-cb5fd115f32a --><h4>Basis for recommendation</h4><!-- end field fd8a090a-7a3a-4957-bbf2-cb5fd115f32a -->","summary":null,"htmlStringContent":"<!-- begin item 5097b64f-b9f1-4bfc-9e82-5c17cf18310a --><!-- begin field 600504b9-61a3-4067-89f6-2b2dab47bb65 --><ul><li>The recommendations on how to manage people who have been in contact with an ‘index case’ of whooping cough are based on expert opinion in the Public Health England (PHE) guideline <em>Public health management of pertussis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">PHE, 2016b</a>].<ul><li>The definition of what constitutes a ‘close contact’ is based on knowledge of the infectiousness of pertussis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Dodhia et al, 2002</a>].</li></ul></li><li>One large randomized controlled trial (RCT) found that prophylaxis with erythromycin reduced the incidence of microbiological infection (but not clinical infection) of household contacts compared with placebo [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Halperin et al, 1999</a>].</li><li>There is some observational evidence that antibiotic prophylaxis is effective at reducing clinical symptoms in vulnerable people (these groups tend to be excluded from RCTs) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Dodhia et al, 2002</a>].</li></ul><!-- end field 600504b9-61a3-4067-89f6-2b2dab47bb65 --><!-- end item 5097b64f-b9f1-4bfc-9e82-5c17cf18310a -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}